Clinical endpoints | Prognostic factors | No. of study | Sample | HR (95% CI) | p-value | I2 (%) |
---|---|---|---|---|---|---|
OS | Gender (female vs. male) | 7 | 711 | 0.53 (0.40, 0.71) | 0.001 | 0.0 |
Age (older vs. younger) | 8 | 830 | 1.10 (0.99, 1.22) | 0.087 | 74.7 | |
TNM stage (III-IV vs. I-II) | 2 | 98 | 3.62 (1.85, 7.08) |  < 0.001 | 30.9 | |
Smoking status (yes vs. no) | 6 | 801 | 1.82 (1.34, 2.47) |  < 0.001 | 0.1 | |
Tumor size (bigger vs. smaller) | 4 | 586 | 1.46 (1.10, 1.93) | 0.008 | 82.0 | |
Metastasis (no vs. yes) | Â | Â | Â | Â | Â | |
Lymph node metastasis | 6 | 780 | 0.26 (0.19, 0.36) |  < 0.001 | 24.7 | |
Pleural invasion | 2 | 415 | 0.39 (0.23, 0.66) |  < 0.001 | 0.0 | |
Pathological features | Â | Â | Â | Â | Â | |
STAS (+ vs. −) | 3 | 339 | 2.23 (1.16, 4.26) | 0.015 | 0.0 | |
Pathological grade (higher vs. lower) | 2 | 191 | 2.77 (0.91, 8.41) | 0.072 | 53.8 | |
Gene mutation (positive vs. negative) | Â | Â | Â | Â | Â | |
EGFR mutation | 3 | 152 | 0.70 (0.35, 1.41) | 0.322 | 0.0 | |
ALK mutation | 2 | 129 | 0.62 (0.13, 3.03) | 0.553 | 60.0 | |
CT manifestations | Â | Â | Â | Â | Â | |
CT morphology (consolidative vs. nodular type) | 2 | 240 | 3.11 (1.90, 5.11) |  < 0.001 | 0.0 | |
Pneumonia type (pneumonia vs. solitary) | 3 | 436 | 5.81 (3.68, 9.19) |  < 0.001 | 0.0 | |
Well-defined heterogeneous GGO (+ vs. −) | 2 | 240 | 2.31 (1.27, 4.19) | 0.006 | 0.0 | |
Spiculated margin (+ vs. −) | 2 | 240 | 0.70 (0.54, 0.92) | 0.012 | 0.0 | |
Lobulated margin (+ vs. −) | 2 | 240 | 1.09 (0.66, 1.80) | 0.722 | 0.0 | |
Air bronchogram (+ vs. −) | 3 | 557 | 1.40 (0.71, 2.78) | 0.336 | 64.8 | |
DFS | Gender (female vs. male) | 3 | 536 | 0.67 (0.49, 0.90) | 0.009 | 26.2 |
Age (older vs. younger) | 3 | 536 | 1.04 (1.01, 1.07) | 0.013 | 0.0 | |
TNM stage (III-IV vs. I-II) | / | / | / | / | / | |
Smoking status (yes vs. no) | 3 | 536 | 1.41 (1.03, 1.93) | 0.032 | 0.0 | |
Tumor size (bigger vs. smaller) | 3 | 487 | 2.50 (0.91, 6.87) | 0.076 | 90.5 | |
Metastasis (no vs. yes) | Â | Â | Â | Â | Â | |
Lymph node metastasis | 3 | 536 | 0.26 (0.19, 0.35) |  < 0.001 | 33.6 | |
Pleural invasion | 2 | 415 | 0.55 (0.25, 1.22) | 0.144 | 55.6 | |
Pathological features | Â | Â | Â | Â | Â | |
STAS (+ vs. −) | / | / | / | / | / | |
Pathological grade (higher vs. lower) | 2 | 123 | 4.46 (1.92, 10.38) | 0.001 | 0.0 | |
Gene mutation (positive vs. negative) | Â | Â | Â | Â | Â | |
EGFR mutation | 2 | 172 | 0.52 (0.09, 2.91) | 0.459 | 72.5 | |
ALK mutation | / | / | / | / | / | |
CT manifestations | Â | Â | Â | Â | Â | |
CT morphology (consolidative vs. nodular type) | / | / | / | / | / | |
Pneumonia type (pneumonia vs. solitary) | 2 | 389 | 5.17 (3.31, 8.08) |  < 0.001 | 37.4 | |
Well-defined heterogeneous GGO (+ vs. −) | / | / | / | / | / | |
Spiculated margin (+ vs. −) | / | / | / | / | / | |
Lobulated margin (+ vs. −) | / | / | / | / | / | |
Air bronchogram (+ vs. −) | 2 | 438 | 1.77 (0.55, 5.67) | 0.340 | 85.1 |